Scholarly article on oxalocrotonate 31540-68-8 from European Journal of Biochemistry p. 400,407

DOI: 10.1111/j.1432-1033.1971.tb01406.x

Source and publish data:

European Journal of Biochemistry p. 400,407 (1971)

Update date:2022-07-28

Topics:

Authors:

Sala-Trepat

Evans Evans

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1111/j.1432-1033.1971.tb01406.x

Full text of DOI:10.1111/j.1432-1033.1971.tb01406.x

Products guided by the article

Product name:oxalocrotonate

Cas No:31540-68-8

R&D Labs maybe for 31540-68-8

shijiazhuang alkay chemicals co..ltd(expird)

Contact:86-311-67692035

Address:2601,juntang building,qiaodong district,shijiazhuang
Foreschem Co., Ltd

Contact:+86-533-3112891

Address:zibo
Synchemie Co., Ltd.

website:http://www.synchemie.com/

Contact:+86-574-87642758

Address:Room 901, Yinyi Bund Building， 132 Renmin Road
Hangzhou Taiyan Trading Co., Ltd(expird)

Contact:+86-13777583958

Address:NO.63, Xingyi Street, Xihu District, Hangzhou, Zhejiang, China
Hubei Lansun Biochemical Pharmaceutical Co., Ltd

Contact:714-6395977

Address:No. 81 Pengcheng Avenue, economic and technological development zone, Huangshi City, Hubei Province,China

Relevant to this article

New syntheses of the C,D-ring pyrromethenones of phytochrome and phycocyanin

Doi:10.1021/jo005531k
(2000)
Synthesis of γ-Spirolactams by Birch Reduction of Arenes

Doi:10.1002/ejoc.202100056
(2021)
Doi:10.1016/S0022-328X(00)84570-2
(1971)
A novel, potent, and orally active VLA-4 antagonist with good aqueous solubility: Trans-4-[1-[[2-(5-Fluoro-2-methylphenylamino)-7-fluoro-6- benzoxazolyl]acetyl]-(5S)-[methoxy(methyl)amino]methyl-(2S)-pyrrolidinylmethoxy] cyclohexanecarboxylic acid

Doi:10.1016/j.bmc.2012.11.003
(2013)
Explosive reactions of platinum-hydroxylamine compounds

Doi:10.1016/0022-5088(91)90330-7
(1991)
Synthesis and biological activity of 5-chloro-N⁴-substituted phenyl-9H-pyrimido[4,5-b]indole-2,4-diamines as vascular endothelial growth factor receptor-2 inhibitors and antiangiogenic agents

Doi:10.1016/j.bmc.2013.01.040
(2013)

Article Doi

DOI: 10.1111/j.1432-1033.1971.tb01406.x